Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

328 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cost-effectiveness of zofenopril in patients with left ventricular systolic dysfunction after acute myocardial infarction: a post hoc analysis of SMILE-4.
Borghi C, Ambrosioni E, Omboni S, Cicero AF, Bacchelli S, Esposti DD, Novo S, Vinereanu D, Ambrosio G, Reggiardo G, Zava D. Borghi C, et al. Among authors: ambrosioni e. Clinicoecon Outcomes Res. 2013 Jul 8;5:317-25. doi: 10.2147/CEOR.S43138. Print 2013. Clinicoecon Outcomes Res. 2013. PMID: 23882152 Free PMC article.
Serum cholesterol levels on admission and survival in patients with acute myocardial infarction treated with zofenopril: a post hoc analysis of the Survival of Myocardial Infarction Long-term Evaluation trial.
Borghi C, Cicero AF, Bacchelli S, Esposti DD, Ambrosioni E; Survival of Myocardial Infarction Long-term Evaluation (SMILE) Study. Borghi C, et al. Among authors: ambrosioni e. Fundam Clin Pharmacol. 2009 Oct;23(5):641-8. doi: 10.1111/j.1472-8206.2009.00704.x. Epub 2009 Jul 28. Fundam Clin Pharmacol. 2009. PMID: 19656211 Clinical Trial.
Zofenopril and ramipril and acetylsalicylic acid in postmyocardial infarction patients with left ventricular systolic dysfunction: a retrospective analysis in hypertensive patients of the SMILE-4 study.
Borghi C, Ambrosioni E, Omboni S, Cicero AF, Bacchelli S, Esposti DD, Vinereanu D, Ambrosio G, Zava D; SMILE-4 Working Party. Borghi C, et al. Among authors: ambrosioni e. J Hypertens. 2013 Jun;31(6):1256-64. doi: 10.1097/HJH.0b013e3283605cd8. J Hypertens. 2013. PMID: 23552127 Clinical Trial.
Randomised comparison of zofenopril and ramipril plus acetylsalicylic acid in postmyocardial infarction patients with left ventricular systolic dysfunction: a post hoc analysis of the SMILE-4 Study in patients according to levels of left ventricular ejection fraction at entry.
Borghi C, Omboni S, Cicero AF, Bacchelli S, Degli Esposti D, Novo S, Vinereanu D, Ambrosio G, Ambrosioni E. Borghi C, et al. Among authors: ambrosioni e. Open Heart. 2015 Aug 3;2(1):e000195. doi: 10.1136/openhrt-2014-000195. eCollection 2015. Open Heart. 2015. PMID: 26288740 Free PMC article.
Zofenopril and Ramipril in Combination with Acetyl Salicylic Acid in Postmyocardial Infarction Patients with Left Ventricular Systolic Dysfunction: A Retrospective Analysis of the SMILE-4 Randomized, Double-Blind Study in Diabetic Patients.
Borghi C, Omboni S, Novo S, Vinereanu D, Ambrosio G, Ambrosioni E; SMILE-4 Working Party. Borghi C, et al. Among authors: ambrosioni e. Cardiovasc Ther. 2016 Apr;34(2):76-84. doi: 10.1111/1755-5922.12175. Cardiovasc Ther. 2016. PMID: 26789425 Free article.
Zofenopril and ramipril in patients with left ventricular systolic dysfunction after acute myocardial infarction: A propensity analysis of the Survival of Myocardial Infarction Long-term Evaluation (SMILE) 4 study.
Borghi C, Omboni S, Novo S, Vinereanu D, Ambrosio G, Ambrosioni E; SMILE-4 Working Party. Borghi C, et al. Among authors: ambrosioni e. J Renin Angiotensin Aldosterone Syst. 2016 Oct 5;17(4):1470320316656480. doi: 10.1177/1470320316656480. Print 2016 Oct. J Renin Angiotensin Aldosterone Syst. 2016. PMID: 27708111 Free PMC article. Clinical Trial.
Efficacy of Zofenopril Compared With Placebo and Other Angiotensin-converting Enzyme Inhibitors in Patients With Acute Myocardial Infarction and Previous Cardiovascular Risk Factors: A Pooled Individual Data Analysis of 4 Randomized, Double-blind, Controlled, Prospective Studies.
Borghi C, Omboni S, Reggiardo G, Bacchelli S, Degli Esposti D, Ambrosioni E. Borghi C, et al. Among authors: ambrosioni e. J Cardiovasc Pharmacol. 2017 Jan;69(1):48-54. doi: 10.1097/FJC.0000000000000440. J Cardiovasc Pharmacol. 2017. PMID: 27798417 Free PMC article.
328 results